Literature DB >> 31179379

Examining Lung Cancer Screening Behaviors in the Primary Care Setting: A Mixed Methods Approach.

Alvie Ahsan1, Eva Zimmerman1, Elisa Marie Rodriguez2, Christy Widman2, Deborah Oates Erwin2, Frances Georgette Saad-Harfouche2, Martin Christopher Mahoney2,3.   

Abstract

While the National Lung Screening Trials (NLST) demonstrated the efficacy of low dose chest computed tomography (LDCT) for lung cancer early detection, utilization of LDCT remains suboptimal. The purpose of this formative study was to understand attitudes and beliefs among primary care clinicians regarding LDCT lung cancer screening as well as to assess gaps in knowledge to identify opportunities for reinforcing personalized lung cancer screening that is accessible and evidence-based. A 20-item closed and open-ended interview was conducted with a targeted group of primary care clinicians (38 respondents; 33 physicians and 5 NPs/PAs). Quantitative data were analyzed using descriptive statistics while qualitative data was analyzed thematically. Although 50.0% of clinicians characterized LDCT as "very effective", only 47.4% of clinicians reported that they frequently or often recommend LDCT as a lung cancer screening tool. Respondents were generally unconcerned with the high rate of false positive test results. The majority of clinicians were referring patients for LDCT based on smoking history, however other factors were also considered (e.g., health status, sex, family history, past medical history, and occupational exposures.) The majority of respondents were knowledgeable about the use of LDCT as a lung screening tool but were unsure about its effectiveness for lung cancer early detection. Some clinicians are recommending patients for LDCT based on factors which are inconsistent with evidence-based guidelines.

Entities:  

Keywords:  Clinician Education; Early Detection; Lung Cancer Screening; Primary Care; Provider Perception

Year:  2019        PMID: 31179379      PMCID: PMC6554719          DOI: 10.11648/j.jctr.20190701.11

Source DB:  PubMed          Journal:  J Cancer Treat Res        ISSN: 2376-7782


  17 in total

1.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Authors:  Michael T Jaklitsch; Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; Scott J Swanson; William D Travis; David J Sugarbaker
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07       Impact factor: 5.209

2.  What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?

Authors:  Stacy Loeb; Edward F Vonesh; E Jeffrey Metter; H Ballentine Carter; Peter H Gann; William J Catalona
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

3.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

4.  Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines.

Authors:  Thejaswi K Poonacha; Ronald S Go
Journal:  J Clin Oncol       Date:  2010-12-13       Impact factor: 44.544

5.  Screening and the number needed to treat.

Authors:  A Richardson
Journal:  J Med Screen       Date:  2001       Impact factor: 2.136

6.  Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center.

Authors:  Jennifer A Lewis; W Jeffrey Petty; Janet A Tooze; David P Miller; Caroline Chiles; Antonius A Miller; Christina Bellinger; Kathryn E Weaver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-22       Impact factor: 4.254

7.  Assessing the delivery of cessation services to smokers in urban, safety-net clinics.

Authors:  Martin C Mahoney; Annamaria Masucci Twarozek; Frances Saad-Harfouche; Christy Widman; Deborah O Erwin; Willie Underwood; Chester H Fox
Journal:  J Community Health       Date:  2014-10

Review 8.  American Cancer Society lung cancer screening guidelines.

Authors:  Richard Wender; Elizabeth T H Fontham; Ermilo Barrera; Graham A Colditz; Timothy R Church; David S Ettinger; Ruth Etzioni; Christopher R Flowers; G Scott Gazelle; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Daniel C Sullivan; William Travis; Louise Walter; Andrew M D Wolf; Otis W Brawley; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2013-01-11       Impact factor: 508.702

Review 9.  Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Frank C Detterbeck; Peter J Mazzone; David P Naidich; Peter B Bach
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

View more
  2 in total

1.  Lung Cancer Screening Knowledge and Perceived Barriers Among Physicians in the United States.

Authors:  Karthik J Kota; Stephanie Ji; Michelle T Bover-Manderski; Cristine D Delnevo; Michael B Steinberg
Journal:  JTO Clin Res Rep       Date:  2022-04-22

2.  Adapting Community Educational Programs During the COVID-19 Pandemic: Comparing the Feasibility and Efficacy of a Lung Cancer Screening Educational Intervention by Mode of Delivery.

Authors:  Elizabeth G Bouchard; Frances G Saad-Harfouche; Nikia Clark; Jomary Colon; Susan A LaValley; Mary Reid; Kristopher Attwood; Maansi Bansal-Travers; Kathryn Glaser
Journal:  J Cancer Educ       Date:  2022-07-15       Impact factor: 1.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.